Category: Biotechnology
Global Biotechnology
-
High Throughput Screening (HTS)
... 2030, growing at a CAGR of 0.9% over the analysis period 2024-2030. Consumables / Reagents, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$16.9 Billion by ... Read More
-
Next Generation Sequencers
... at a CAGR of 17.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$26.6 Billion by the end of the ... Read More
-
Biobanks
... 7.7% over the analysis period 2024-2030. Physical / Real, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$108.4 Billion by the end of the analysis period. ... Read More
-
Biomarkers
... 13.7% over the analysis period 2024-2030. Safety, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$89.8 Billion by the end of the analysis period. Growth in ... Read More
-
Mesenchymal Stem Cells (MSC)
... 2030, growing at a CAGR of 12.2% over the analysis period 2024-2030. Bone Marrow, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$3.4 Billion by the ... Read More
-
Predictive Diagnostics
... CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$821.4 Million While China is Forecast to Grow at 9.9% CAGR The Predictive Diagnostics market in the U.S. is estimated at ... Read More
-
Personalized Medicines
... CAGR of 4.6% over the analysis period 2024-2030. Personalized Nutrition & Wellness, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$484.0 Billion by the end of ... Read More
-
Antimicrobial Susceptibility Testing
... at a CAGR of 3.4% over the analysis period 2024-2030. Manual Products, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Microplate Systems
... CAGR of 4.6% over the analysis period 2024-2030. Readers, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$851.2 Million by the end of the analysis period. ... Read More
-
Aerospace & Life Sciences Testing, Inspection, and Certification
... 2024, is expected to reach US$48.4 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. In-House, one of the segments analyzed in the report, is expected to record a 4.2% ... Read More
-
Antibody Production
... CAGR of 10.4% over the analysis period 2024-2030. Monoclonal Antibody, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$27.4 Billion by the end of the analysis ... Read More
-
Molecular Breeding
... CAGR of 17.6% over the analysis period 2024-2030. Marker-Assisted Selection (MAS), one of the segments analyzed in the report, is expected to record a 18.1% CAGR and reach US$11.7 Billion by the end of the ... Read More
-
Microbiome Sequencing Services
... at a CAGR of 18.2% over the analysis period 2024-2030. Synthesis, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.3 Billion by the end of the ... Read More
-
Cell Analysis
... CAGR of 5.5% over the analysis period 2024-2030. Flow Cytometry Products, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$10.3 Billion by the end of the ... Read More
-
Biotechnology Reagents
... CAGR of 4.4% over the analysis period 2024-2030. Chromatography, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$40.6 Billion by the end of the analysis period. ... Read More
-
Animal Feed Additives
... at a CAGR of 5.4% over the analysis period 2024-2030. Amino Acids, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$20.7 Billion by the end of ... Read More
-
RNA Interference (RNAi)
... at a CAGR of 10.0% over the analysis period 2024-2030. Drug Discovery & Development, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$118.1 Billion by the ... Read More
-
Drug Discovery Technologies
... at a CAGR of 8.7% over the analysis period 2024-2030. Small Molecule Drugs, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$92.7 Billion by the end ... Read More
-
Coatings for Medical Devices
... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Anti-Microbial, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$7.7 Billion by the end ... Read More
-
Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025
... This report focuses on cell and gene therapy contract development and manufacturing organization (cdmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over ... Read More
-
Cell Banking Outsourcing Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
CRISPR Gene Editing Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Liquid Biopsy
... CAGR of 17.9% over the analysis period 2024-2030. Assay Kits, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$12.8 Billion by the end of the analysis ... Read More
-
Microcarriers
... 8.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in ... Read More
-
Preparative and Process Chromatography
... 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Process Chromatography, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$8.9 Billion by the ... Read More
Research Assistance
